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Abstract
VASCULAR EFFECTS OF PHYSALIA PHYSALIS VENOM
by
Jose S. Loredo
The purpose of this study was to identify the effects of Physalia 
physalis (Portuguese Man-of-War) venom on vascular smooth muscle and 
elucidate its mode of action. We utilized the in vivo approach by 
functionally isolating the skeletal muscle vasculature of the dog's 
hind leg, and the in vitro approach by studying rabbit arterial ring 
segments.
Twelve male mongrel dogs were anesthetized with 35 mg/kg sodium 
pentobarbital. Arterial pressure was measured from the aortic arch and 
the cranial femoral artery, a cephalad branch of the femoral artery.
The skeletal muscle venous blood flow of the hind leg was functionally 
isolated. Femoral vein blood flow and pressure were monitored from 
ports in the extracorporeal flow sensor. Four of the twelve dogs were 
also subjected to lumbar sympathetic chain stimulation. Lingual, renal, 
femoral and central ear arterial ring segments were excised from 19 
male California rabbits, weighing less than 2.7 kg. These vascular 
segments were each mounted on an isometric tension measuring device and
placed in a 15 ml bath filled with Krebs-Henseleit solution aerated 
with 95% O2 and 5% CC^. Each ring was set at its optimum basal tension
by applying passive stretch and inducing constriction with 
norepinephrine. The venom was added to the bath in logarithmically 
spaced doses, ranging from 0.021 yg/ml to 4.28 yg/ml.
It was found that Physalia venom increased skeletal muscle blood
flow when it was injected into the cranial femoral artery. The effect 
of the venom was diminished by cimetidine and tripelennamine (histamine 
receptor blockers), and was blocked by sodium meclofenamate (prosta­
glandin synthesis inhibitor). The venom transiently reversed 
sympathetic vasoconstriction, and no change of this effect was noted 
with infusion of cocaine. Venous blood samples taken after infusion of 
the venom revealed higher histamine levels than the control samples.
The venom produced relaxation of the arterial ring segments in a 
sigmoid dose-dependent manner. The femoral artery displayed the 
greatest sensitivity to the venom, but the highest efficacy was 
demonstrated on the lingual artery. This effect was almost completely 
blocked by pretreatment with sodium meclofenamate. Venom induced 
relaxation was slightly enhanced by pretreatment with propranolol, but 
not significantly from control. Quinacrine (phospholipase inhibitor) 
and atropine had no effect on venom-induced relaxation.
These observations suggest that Portuguese Man-of-War venom is a 
vasodilator, and that the primary mode of action is through stimulation 
of the synthesis of vasodilatory prostaglandins from substrates that 
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Diagramatic representation of the in vivo canine 
skeletal muscle preparation.
Diagramatic representation of the in vitro rabbit 
arterial ring segment preparation.
Representative polygraph time-course tracing of the 
vasoactive effects of isoproterenol, PGE-|, histamine, 
norepinephrine, and acetylcholine.
Long- and short-duration responses of blood flow to 






Histamine content in arterial and venous blood after 
treatment with Physalia venom of the canine skeletal 
muscle vasculature.
Figure 5.
Effect of Physalia venom on the isolated skeletal muscle 
vasculature of the dog.
Effect of Physalia venom in the isolated skeletal muscle 
vasculature of the dog after systemic treatment with 
pharmacological blockers.
In vivo effect of Physalia venom when infused at the 
peak effect of histamine, norepinephrine, and PGE-|.
Representative time-course polygraph tracing of the 
action of norepinephrine on the in vitro preparation.
Norepinephrine dose response curves for the vitro 
femoral, renal, central ear, and lingual arterial ring 
segments.
Representative time-course polygraph tracing demon­
strating the effect of increasing static tension on 
the response to norepinephrine by the arterial ring 
segments.
Static tension versus active tension curve for the Jji 
vitro femoral, renal, central ear, and lingual arterial 
ring segments.
Representative time-course polygraph tracing of the 











Figure 14. Physalia physalis venom dose response curve in the 
in vitro femoral, renal, central ear, and lingual 
arterial ring segments.
Effect of Physalia venom after pretreatment of the 
in vitro arterial ring segments with the pharma­
cological blockers.





Physalia physalis, also known as Portuguese Man-of-War or Blue­
bottle, is a coelenterate which can be found in large quantities in the 
coastal regions of Florida during the winter. These jellyfish can 
become a nuisance to swimmers who have the ill-fated luck to come in
contact with them.
The Portuguese Man-of-War is composed of several well defined
It was believed to be a colony composed of atanatomical structures.
least four different types of organisms or structures: the float, the
27,29gastrozooids, the reproductory organs, and the fishing tentacles.
The study of the Portuguese Man-of-War in the laboratory is compli­
cated by the problem of its poor survival outside of the ocean. Lane 
reported that the contact of the jellyfish on the bottom and sides of 
a tank in the laboratory triggers the loss of protein from a protein- 
rich fluid in the gastrovascular space of P. physalis. He believes
26that this is the reason for its fast deterioration while in captivity.
This cell-free fluid, which also contains lipids, may function as a
50transport medium, much like mammalian blood or invertebrate hemolymph.
The colorful float which is always seen above the water is essen­
tially a gas-filled bag, believed to be used by the animal to travel 
aided by the wind. The gastrozooids are structures that function as 
the digestive system of £. physalis and are located immediately under 
the float. They are very sensitive to glutathione, a substance that 
is liberated when an animal is injured or when dead tissue decomposes. 
The third major specialized tissue of £. physalis, the gonozooid, is
1
2
responsible for reproduction. These consist of male and female 
structures which grow alongside the gastrozooids. 27
The largest part of the Portuguese Man-of-War is composed of the
dactylozooids or fishing tentacles. These can be from 40 to 100 feet
pp
long in the adult jellyfish.
that has longitudinal bands of muscle used to reel up captured food
toward the writhing gastrozooids. But the most characteristic feature
of the tentacles is the specialized stinging cells which are the actual
food-gathering devices. These nematocysts are hollow spheres which
29 They contain a tube­
like structure which projects out when they come in contact with any
The tentacle is a thread-like structure
come in a range of sizes from 8.8 to 42.3 ym.
However, both mechanical and chemical stimuli seem to beobject.
43required to elicit nematocyst discharge.
proposed that the cnidocil apparatus, a flagellum-like structure on 
the tentacle, is the mechanical and sensory receptor for nematocyst 
discharge.
in the nematocysts is delivered to the passing organism, 
purpose of this study to elucidate a bit more the physiological effects
Several investigators have
43,12 It is in this manner that the potent venom contained
It is the
of this venom.
The nematocysts can be frozen at -20°C for up to three years and
28,29still be able to release their venom. The composition of the 
venom itself is primarily proteinaceous. Some free fatty acids and
cholesterol are also present, together with high levels of glutamic
27,28,29,51acid and low levels of aromatic amino acids. According to
Burnett, six enzymatic activities have been observed: ATPase, non-
3
g
specific aminopeptidase, RNase, DNase, AMPase, and a fibrinolysin. 
Purification of the P^. physalis DNase has revealed a non-specific 
endonucleolytic action. The molecular weight is approximately 75,000 
daltons, and the enzyme is active at a wide pH range. Such an enzyme
can also be found in the venoms of snakes, wasps, and the sea 
4.?nettle. Stillway has also reported phospholipase A and B activity
but his finding has been51in the Portuguese Man-of-War venom,
gquestioned by others.
Prolonged study of the Portuguese Man-of-War venom has been
difficult due to its lability. At room temperature, aqueous solutions
of lyophilized venom lose 95% of their activity within one hours, and
all of their activity in 5 minutes if heated to 60°C.
activity can be decreased by diluting the venom in a phosphate buffer 
22 In addition to heat, organic solvents reduce the 
effectiveness of the venom; therefore, application of alcohol to skin
28,32 Loss of
at a pH of 6.3.
injured by the Portuguese Man-of-War may have some palliative 
27,29effects.
According to Lane, crude venom is about 75% as poisonous as cobra
27 Most laboratory animals succumb rapidly to the venom's effect.venom.
Their deaths seem to be the result of paralysis of the respiratory
27,28,29,30system and heart arrhythmias. The lethal factor has been
recently identified as a rod-shaped protein, composed of three different 
glycosylated subunits in equal molar-ratios. Its molecular weight is
about 240,000 daltons, and sedimentation coefficient is 7.8 S. The
52LD5q in mice for this protein is approximately 200 yg/kg. However,
4
there are at least two animals which appear to be immune to the toxicity
These are the loggerhead turtle, which has been 
seen by fisherman feasting on a patch of Portuguese Man-of-War, and 
the fish Nomeus gronovii, which lives between the tentacles of P.
of P_. physal is venom.
physalis and in whose stomach many discharged and intact nematocysts 
are found.^
PHYSIOLOGICAL EFFECTS OF PORTUGUESE MAN-OF-WAR VENOM
In the neurogenic heart of the land crab, the venom inhibited the
normal heartbeat while at the same time stimulated the neurons of the
31 The venom also proved 
35effective in blocking neuronal conduction in the sciatic nerve.
cardiac ganglion to fire at an increased rate.
For
27this reason, some authors have thought it to be a neurotoxin.
After these observations, it became of interest to see how the
In the rat, low doses of thevenom would affect a myogenic heart, 
venom produced an increase in the duration of the Q-T interval suggest­
ing a slowing down of ventricular repolarization. As the dose of venom 
was increased, the P-R interval decreased and the P waves became
inverted. This suggested an increase of the A-V node conductivity 
with retrograde conduction, possibly caused by an ectopic pacemaker. 
Larsen suggested that the venom was causing a generalized depolarization 
of the cell membranes by interfering with the Na-K pump. This depolari­
zation would render the S-A node inactive and an ectopic focus would
34 The effects of the venom in the dog were similar to thosetake over.
However, in the dog it was observed that the venom-induced
22arrhythmias could be reversed by injecting 10 ml of isotonic KC1.
in the rat.
It was also noticed that after venom infusion serum potassium was
elevated while serum sodium was decreased. This data supported the
theory that the venom inhibited the Na-K pump, thus reducing active
22ion transport across the cell membrane, 
that other factors, such as renal failure and hemolysis, can produce 
the same electrolyte changes. The ability of Portuguese Man-of-War
However, it should be noted
5
6
venom to disrupt electrolyte transport across a membrane was also
observed by Lane on an ATPase enzyme system from the gill of the
land crab, Cardisoma guanhumi; this is a Na+, K+, and Mg+ activated
ATPase complex which the crab utilizes as an ion regulator. Physalia
32venom disrupts all components of this epithelial enzyme system.
Hastings found that the venom increased carotid artery pressure 
in the dog. This increase was secondary to a rise in stroke volume. 
The increase of myocardial contractility and the rise in stroke volume 
can be explained by the venom-induced reduction of the intracellular
potassium. Another possible explanation would be a catecholamine
22 Garriott also observed that the venomreleasing effect of the venom.
prolonged the pressor effect of epinephrine. He postulated that the
18venom was probably inhibiting a monoamine oxidase.
In guinea pig and rat ileum preparations, venom at a concentration 
of 20 yg/ml induced contractions similar to those induced by acetyl­
choline, serotonin, and histamine. However, the addition of atropine, 
methysergide, and antihistamine to the system did not block the ileum­
contracting effect of the venom. Serotonin could not be blocked with 
methysergide in these experiments. However, analysis of the venom for
serotonin revealed that it could not contain more than 0.05% of sero­
tonin, a quantity too small to cause any observable contractions of 
the ileum. Hexamethonium, an autonomic ganglion blocker, also did 
not block the venom-ineduced ileum contractions. Very high doses of 
venom rendered the gut incapable of any contraction. It was concluded 
that the venom-induced ileum contraction was not mediated via acetyl-
7
18choline, histamine, nor serotonin, nor was it ganglionic in origin.
The ability of the venom to contract guinea pig ileum was also very
similar to that observed with the kinins. However, venom sedimentation
characteristics indicated that the contracting factor was larger than 
either bradykinin or kallidin.^
In vitro studies of the _P. physalis venom have demonstrated that
the venom increased, the Na+ transport across the frog skin. However,
the Na+ transport inhibition produced by ouabain was not affected by
Physal ia venom.^ Therefore, it appears that P^. physal is venom affects
the sodium transport across frog skin without a direct action on the
22sodium pump mechanism itself, as has been suggested earlier, 
finding of interest is that the venom was able to reverse the inhibition 
of Na+ transport caused by Ca++. This competition suggests that Ca++
Another
and the venom might have a common site of action, 
in the various systems described thus far can be explained by the 
venom's ability to increase the Na+ permeability across cell membranes 
without directly affecting the Na-K ATPase system, as previously 
suggested by Larsen.^
At one time it was believed that the venom had a histamine 
releasing effect on mast cells, as described by (jvnas.^ 
that Uvnas' histamine-releasing effect was probably due to tentacular
The venom's actions
Lane believes
tissue contamination of his Portuguese Man-of-War venom preparation,
28since he failed to elicit this response to any significant extent.
However, recent studies by Flowers and Hessinger have shown that
histamine is obtained from mast cells that have been treated with P.
8
physalis venom, but the degranulation of the mast cells is due to a
17cytolytic effect rather than a secretory effect.
Early cardiovascular experiments with £. physal is venom revealed 
29no hemolysis. However, subsequent trials clearly demonstrated that
52,37 The work of Lin andthe venom contains a hemolytic factor.
Hessinger has shown that the hemolytic action of Portuguese Man-of-
War venom is a stoichiometric rather than an enzymatic process. Since
phospholipase ^ anc* trypsin-treated rbc's are somewhat resistant to
venom hemolysis, they have suggested that both the lipid and protein
components of the rbc membrane are involved in the hemolytic process.
They have also found that rbc glycophorin suppresses the hemolytic
37action of Portuguese Man-of-War venom.
Lane summarized the action of the venom by stating that "Physalia 
venom owes its general biological effectiveness to its involvement
,,32with membrane transport phenomena.
PRINCIPLES OF BLOOD FLOW CONTROL
Before examining the goals of this study, it is important to 
briefly mention the different hypotheses of local blood flow control
and the physics of blood flow.
The circulatory system has three major control systems for blood
flow: nervous, humoral, and local controls. Our experiments fall in
the realm of humoral control.
Humoral regulation of the circulatory system is that provided by
substances in the body fluids. Both vasoconstrictors and vasodilators
can be found in the body. Vasoconstrictor substances such as the
catecholamines are closely related to the sympathetic nervous system. 
Vasoconstrictor agents such as vasopressin (ADH) and angiotensin also 
play an important role in the control of blood pressure. Among the 
body's vasodilatory agents are bradykinin, histamine, and serotinin. 
Bradykinin and histamine are released when the tissues are injured.
Serotonin can produce vasoconstriction in some tissues.
Prostaglandins are tissue compounds that are derived from arachi- 
donic acid, and have been implicated in blood flow control. "The wide­
spread presence of prostaglandins in the tissues and their diverse 
actions, suggest that they play a significant role in the control of 
blood flow, especially for local control.
Blood flow through a peripheral vessel is determined almost 
entirely by two factors: the pressure difference across the vessel and 
vessel radius. Major changes in vascular resistance are produced by 




4inversely to r , it follows that a small change in radius will produce
5a pronounced effect in vascular resistance.
PURPOSE AND HYPOTHESIS
The purpose of this study is to examine the hemodynamic effects 
of Physalia physalis venom on skeletal muscle vasculature as well as
in other vascular beds, and to determine its mode of action.
As discussed above, studies have suggested that this venom
increases the permeability of sodium at the cellular membrane level.
If we assume that the venom utilizes the same mechanism of action in
vascular smooth muscle as it did in the above mentioned tissues, we
could hypothesize that its effect in the vasculature would be con­
striction. This constriction would come about when the smooth muscle
cell membranes are depolarized by the influx of sodium ions, secondary
to the venom-induced increase in peremability., This hypothesis was
partially supported by a pilot experiment that demonstrated a biphasic 
effect--i.e. vasoconstriction followed by vasodilation. This response
was not dose related. Our second objective is to study the cellular




Prostaglandin E-| was graciously provided by Dr. John Pike (Upjohn 
Co., Kalamazoo, MI). Sodium meclofenamate was obtained from Warner- 
Lambert/Park-Davis, Detroit, Michigan. Acetylcholine, isoproterenol 
HC1 , norepinephrine, histamine phosphate, atropine sulfate, propranolol 
HC1 , phentolamine, cocaine, cimetadine HC1, and tripelennamine HC1 were
all reagent grade. Histamine assays were performed by Lester A. 
Flowers. Portuguese Man-of-War venom was kindly provided by Dr. David 
A. Hessinger who prepares his own venom from Portuguese Man-of-War 
specimens that he captures off the coast of Florida. His method for
isolation of the venom is similar to that used by other investigators
52and has been described elsewhere. Briefly, the nematocysts are first
separated from the tentacular material, and are made to discharge their 
contents. After centrifugation, the supernatant fluid contains high 
concentrations of the venom. The undischarged nematocysts left in 
the precipitate are then homogenized and centrifuged to obtain a second
fraction of venom which is not as concentrated as the first fraction.
The discharged nematocysts are also collected and homogenized. After 
centrifugation, a third fraction of venom is obtained, which contains 
the lowest activity.
Twelve adult male mongrel dogs ranging from 16 to 22 kg in weight 
were used in this series of experiments. We chose not to use female 
dogs as their vascular compliance appears to vary during the estrus 
cycle. All of the animals utilized appeared alert and in good health
12
13
We chose to use the skeletal muscle vascularbefore each experiment.
bed of the whole hind limb, due to the ease of its functional iso­
lation (Fig. 1).
The dogs were anesthetized with 35 mg/kg of sodium pentobarbital, 
administered via the cephalic vein. After shaving the anatomical areas 
on the dog involved in the experiment, the animals were placed in a 
supine position and secured to the dog board. To insure adequate 
ventilation and to maintain the arterial blood gases at a constant and 
normal level, a tracheostomy was performed and a Bennett intermittent 
positive pressure respiratory, model PR-1, and a gas mixer, which 
combined 100% oxygen with room air, were utilized.
Arterial and venous blood gases as well as pH, were monitored with 
an Instrumentation Laboratory, Inc. pH Blood Gas Analyzer, Model 213.
The next step was to place a permanent catheter in the right
cephalic vein through which the anesthetic, heparin solution, and 
pharmacological blockers were infused. The aortic blood pressure was 
monitored by a Statham P 23 ID pressure transducer via a catheter 
advanced from the left femoral artery up to the aortic arch; its 
purpose was to insure that the drug and venom dosages were not producing 
a systemic effect. The right femoral artery was carefully dissected 
and a catheter inserted retrograde in the cranial femoral artery to 
its origin from the right femoral artery. A Statham P 23 ID pressure 
transducer was used with this catheter to measure the arterial component 
of perfusion pressure and to collect arterial blood samples.
















Fig. 1. The jm vivo experimental preparation.
15
functionally isolated by ligating the medial and lateral saphenous 
veins and by placing a tourniquet around the hock of the leg. These 
steps were taken to prevent contamination of the venous blood from 
the skeletal muscle vascular bed with blood from the paw and skin. 
Blood flow was measured by a square wave electromagnetic flow meter 
flow sensor (Carolina Medical Electronics, Inc 
The flow sensor was introduced into the right femoral vein via an 
extracorporeal loop. The venous component of perfusion pressure and 
venous blood samples were obtained from ports in this sensor. We 
chose the cannulating flow sensor over a perivascular magnetic flow, 
sensor because we did not know what the reaction to the venom would
Model EP 300 P2).• 5
If the venom were to change the hematocrit or cause a strong 
vasoconstriction, then the perivascular flow sensor would have been
be.
ineffective in measuring blood flow rate. Needle electrodes were used
to record the standard limb lead II electrocardiogram.
The standard limb lead II of the EKG, aortic blood pressure, 
femoral artery blood pressure, femoral vein blood pressure, and 
femoral vein blood flow, were continuously displayed on an eight 
channel polygraph (Grass Model 7D) and recorded on magnetic tape
(Ampex PR 500).
The purpose of these steps was to observe the changes in vascular 
resistance produced by Physalia physalis venom and several other vaso­
active drugs. Vascular resistance was calculated by the ratio of the 
arteriovenous pressure differences and the venous blood flow rate, and 
was expressed in peripheral resistance units. At the end of each
16
experiment the anesthetized animal was terminated with an intracardiac 
injection of a saturated KCL solution. Statistical significance was 
determined by the Two-way Analysis of Variance in conjunction with the 
Duncan New Multiple Range Test.
The first eight experiments had three distinct parts. First, 
acetylcholine, isoproterenol, norepinephrine, histamine, and prosta­
glandin E-j were administered in three logarithmically different concen­
trations (0.001, 0.1, and 0.1 yg/kg). Isoproterenol was given at a 
concentration of 0.0005 and 0.001 yg/kg; this was necessary because 
of its high activity, to avoid any systemic effects.
These drugs were infused through the cranial femoral artery 
catheter. The purpose of this was to select a dose of drug to use 
as a challenging concentration for the pharmacological blockers used
later in the experiment.
Next, Portuguese Man-of-War venom was infused in three logarith­
mic concentrations: 0.02, 0.2, and 2.0 yg/kg in order to establish a 
dose-response relationship. Enough time was provided for the blood 
flow to come to a steady state before proceeding to the next venom
dose.
We attempted to block the action of the venom by using five known 
pharmacological blocking agents: atropine (a muscarinic receptor 
blocker), propranolol (a beta adrenergic receptor blocker) phento- 
lamine (an alpha adrenergic receptor blocker), tripelannamine and 
cimetidine (H-j and receptor blockers respectively), and sodium 
meclofenamate (a prostaglandin synthesis inhibitor). Propranolol,
17
phentolamine, atropine, and cimetidine were given in concentrations of 
1-2 mg/kg; tripelennamine in concentrations of 2.5 mg/kg, and sodium 
meclofenamate in concentrations of 5 mg/kg. The blockers were given 
gradually (over about five minutes) to minimize their systemic effects 
and avoid complications. To verify the effect of the blocker, a
challenging dose of agonist was administered. If blockade was
effective, the venom was administered. If the dose of agonist was 
not suppressed, more blocking agent was administered and the verifi­
cation process repreated. The venom concentration used was 0.2 yg/kg, 
because this was the dose that gave us the most consistent response 
throughout the experiments. Before every drug injection the catheter
was flushed with one ml of normal saline. All doses, with the
exception of the blockers, were given in one ml volumes, and flushed
in with one ml of normal saline.
In a second series of experiments, four dogs were prepared in the
same manner as the first eight, except that the skeletal muscle iso­
lation was done on the left hind leg. The left lumbar sympathetic chain 
was isolated and severed just caudally to L^,
was stripped from its nerve sheet and placed over a bipolar platinum 
stimulating electrode. The dogs were cholinergically blocked at the 
start of the experiment, with 1-2 mg/kg atropine to avoid any skeletal 
muscle vasculature vasodilation from cholinergic sympathetic nerve
and the distal free end
endings. Then we proceeded to infuse predetermined concentrations of 
norepinephrine, prostaglandin E-j, and histamine. At the point of their 
maximum effect, we infused 0.6 yg/kg of venom. Following this, we
18
administered antihistamine to block any histamine-releasing effect that 
the venom might have, as was suggested by the literature, 
steps were taken to see if there was any interaction between the effect 
of the known vasoactive substances and the venom.
53,17 These
The left lumbar sympathetic chain was stimulated with 12 Volts 
at 20 Hz. At the point of maximum sympathetic-induced vasoconstriction 
we infused 0.6 yg/kg of venom. The same procedure was attempted again 
after the systemic infusion of 2 mg/kg of cocaine. These steps were 
taken to see if P. physalis venom interfered with sympathetic trans­
mission or with adrenergic receptor sensitivity.
In vitro Experiments
The action of the Physalia venom was further evaluated by a direct
method of recording tension changes in the wall of small blood vessels 
as described by Sevan.
rabbts weighing less than 6 lbs. The animals were sacrificed by a 
sharp blow to the back of the head. As soon as the animal was unre-
For this section we used adult male California
sponsive, we proceeded to remove segments of lingual, femoral, renal, 
and central ear arteries, which were immediately placed in a petri dish 
with cool Krebs-Henseleit solution aerated with 95% and 5% CC^. 
Krebs-Henseleit solution had the following composition in millimoles/
The
liter:
NaCl - 118 
KC1 - 5.4 
NaHC03 - 12.5 
CaCl2 • 2H20 -
Under a dissecting microscope the vessels were carefully cleaned of 
extravascular tissue, with care being taken not to over-stretch them.





A straight 3 mm artery segment devoid of branches was chosen for the 
experiment. The vessel's lumen diameter ranged from 0.3 to 1.5 mm 
depending on the type of artery. A platinum U-shaped wire, 100 ym 
in diameter, and a stainless steel tube, 200 ym in diameter, were 
passed through the lumen of the arterial segments. The stainless steel 
tube was hung from a forked rod which was connected to a PT 3 Grass 
strain gauge, and the dependent ends of the platinum wire were fixed 
to an L-shaped plastic rod via a gate. The L-shaped rod could be moved 
up or down with a microadjustor, thus enabling us to produce tension 
on the walls of the vessels (Fig. 2). This preparation was then 
immersed into an organ bath containing 15 ml of aerated Krebs-Henseleit 
solution at 37°C. Tension records were made on an 8-channel Grass
polygraph. Model 7D. The vessels were allowed to equilibrate in their 
new environment for 60 minutes at a starting static tension of 300 mg.
This tension was obtained by manipulating the microadjustor by incre­
ments of 100 mg over a period of 3 minutes, thus protecting the vessel 
from being over-stretched. All drug dosages were placed directly into 
the bath solution. The stock concentration was adjusted so that only
50 yl of solution were delivered per dose, 
were prepared the same day of the experiment with chilled Krebs- 
Henseleit solution, and were kept in ice.
All drugs and venom doses
The venom doses used in our jrn vitro preparation were adjusted
so that they would be comparable to those used in the dog experiments. 
The in vivo venom concentrations used were 0.02, 0.2, and 2.0 yg/kg.











Fig. 2. The in vitro experimental preparation.
21
sidering the dog's blood equivalent to the Krebs-Henseleit solution 
bathing the arterial ring segments. The total venom given to an 
average weight mongrel dog (23.1 kg) was divided by the average blood
volume in a dog's hind limb (94.1 ml/kg x 2.75 kg) to obtain venom
3in yg/ml of bath solution. The highest in vivo venom concentration 
(2.0 yg/kg) was equivalent to 0.214 ug/ml of bath solution.
These experiments had four different sections. Due to the length 
of the experiment, each arterial segment was used for only two 
sections. In the first section of these experiments a norepinephrine
dose response curve was obtained. The norepinephrine dose ranged from 
10‘9M to 10‘3M. After each norepinephrine dose, the bath solution was 
changed as many times as needed for the arterial tension to return to 
the starting static tension. The vessel was then allowed to equili­
brate for about ten minutes before the next dose was administered. A
norepinephrine (NE) dose response curve was constructed for each of
From these curves we obtained the NEthe four different arteries.
concentration which produced 70% of the maximum NE-induced contraction
(NE ED70).
After a 60-minute equilibration period at zero static tension.
for the four vessels was administered and the tensionthe NE ED 70
changes recorded. The bath solution was then changed until the arterial
Before the next NEtension returned to the beginning static tension.
ED^g, the static tension was increased by 200 mg and the vessel was 
allowed to equilibrate for a few minutes at the new tension. This 
procedure was repeated until a 200 mg increase in static tension did
22
not produce an increase in active tension with the NE ED With these70*
data an active tension versus static tension curve was constructed for
each artery, and the static tension at which the NE ED^g produced its
) was selected.maximal active tension (classically designated as L
The third section of the experiment consisted of a dose-response
max
The vessels were allowed tocurve for Portuguese Man-of-War venom, 
equilibrate in the bath solution at their L for 60 minutes. NEmax
ED™ was then added to the baths, the ED was not used because it7080
only produced a sustained contraction in about 50% of the artery
Once the NE dose produced a contracted steady state, thesegments.
Physal ia venom was administered in six different concentrations: 0.021,
0.107, 0.21, 1.07, 2.14, and 4.28 yg/ml of bath solution. After each
added. The vesselvenom dose the bath solution was changed and NE ED80
From these data a dose responsewas then allowed to return to Lmax*
curve for the venom was constructed for the four different arteries.
In the fourth and final section, we tested the effect of various
blockers on the vascular response to the venom. Atropine, propranolol, 
sodium meclofenamate, and quinacrine (a phospholipase A^ inhibitor) 
were used. The arterial segments were prepared as before. Each seg­
ment was only exposed to one kind of blocker per experiment. The 
procedure was similar to that in other sections. After the customary 
one hour equilibration period, NE ED
bility of the arteries. When the vessels were at the contracted 
steady state, a challenging concentration of acetylcholine (10"^M), 
isorpoterenol (80 yg/ml), and arachidonic acid (40 yg/ml) were given.
was given to determine the via-80
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The agonists acetylcholine and isoproterenol were dissolved in chilled 
Krebs-Henseleit solution and delivered in 50 yl of solution. Arachi-
donic acid was dissolved in 0.2 M Trizma base and delivered in 60 yl
of solution; before delivering this, however, 60 yl of 0.2 M Trizma 
base was placed in the bath to see if it had any vasoactivity of its
Following this the bath solution was changed until the vessel
After a few minutes for equilibration, the
and at the steady state,
own.
tension returned to Lmax*
arterial segments were contracted with NE ED80
Physalia venom was applied at a concentration which produced an easily 
identifiable effect; this concentration ranged from 1.07 to 4.28 yg/ml, 
but was usually 2.14 yg/ml of bath solution, 
changed again and the pharmacologic blockers added in the following 
concentrations: atropine 6 yg/ml; propranolol 4 to 12 yg/ml; Na meclo- 
fenamate 10 to 20 yg/ml; and quinacrine 2*10"^ to 4*10"^ moles/1.
The arterial segments were incubated with atropine and propranolol 
for 30 minutes, while Na meclofenamate and quinacrine were allowed to 
remain in the bath solution for one hour before any other procedure
The bath solution was
was attempted. After the incubation period, the vessels were again 
contracted and, at the steady state, their respective agonists were
If the agonist's effect was blocked, then the pre­administered.
determined venom concentration was administered and its action com-
If the blocker did not abolish itspared with its pre-blocker effect, 




The blood flow response to an injected acetylcholine bolus was 
characterized by a sharp rise in blood flow which was immediately 
followed by a rapid decline; the decrease in blood flow was not as 
sharp as the rise. The blood flow stabilized at its new steady state 
level within 60 to 90 seconds. This new steady state level was 
usually very close to that prior to the infusion.
The norepinephrine (NE) bolus produced a small rise in blood flow, 
immediately followed by a sharp decline, ending below the beginning 
blood flow level. After the maximum vasoconstriction produced by NE,
the blood flow increased very slowly, finally not only reaching the 
beginning steady state level, but going beyond it for about 30 seconds 
before it returned once more to the beginning steady state blood flow
1 eve!.
The blood flow response to the isoproterenol bolus was character­
ized by a sharp rise followed by a slow decline. Isoproterenol was 
one of the most active substances used in these experiments; the 
greatest blood flow rates were seen with it, and the dose used had to 
be decreased several times to avoid systemic effects.
The prostaglandin E-| (PGE-j) bolus produced a moderate rise in 
blood flow followed by a very slow decline. The decrease in blood 
flow took several minutes to come to the original steady state blood
flow level.
The blood flow response to histamine was a moderate rise followed
24
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by a moderate decline, returning to the beginning steady state blood
The histamine blood flow response,flow in about 60 to 90 seconds.
more than any of the others, resembled a normal bell shaped curve.
There was much variability in blood flow levels for each substance
from experiment to experiment. However, a general representation of 
the blood flow patterns described above appear in Figure 3.
We graphically analyzed the effects of Physalia physalis venom 
on the blood flow of the isolated skeletal muscle of the righ hind limb. 
The time-course of blood flow appeared to fall in two general cate­
gories (Fig. 4). In the first type of response, the long-duration 
response, the blood flow increased rapidly and then decreased very 
slowly, requiring several minutes to come to the beginning resting 
value. In the second type, or the short-duration response, the blood 
flow increased at a moderate rate and also decreased at a moderate
rate, the phase of decreasing flow being somewhat slower than the phase
In this blood flow response to the venom, the 
beginning steady state level was achieved much faster than in the 
first type of response.
Blood samples taken before and during the effect of the Portuguese
of increasing flow.
Man-of-War venom were analyzed for histamine content in four of the
dogs. Control samples were taken before any venom administration 
(CA and CV). Venous blood histamine concentration taken after arterial 
venom infusion was significantly greater than either the arterial 
blood or the arterial and venous control levels (p < 0.01). Also
the venous blood histamine content increased with increasing venom
26
Fig. 3. Representative polygraph tracings of the effects of (A) 0.001 
yg/kg of isoproterenol, (B) 0.001 yg/kg of Prostaglandin E-,, 
(C) 0.01 yg/kg of histamine, (D) 0.01 yg/kg of norepinephrine, 
and (E) 0.01 yg/kg of acetylcholine. These effects were 
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Fig. 4. Effect of Physalia Physalis venom on the time-course of blood 
flow of the canine hind limb. Two types of venom-induced blood 
flow changes were observed. (A) Representative polygraph 
tracings of the long duration response. The arrows denote 
the infusion of 0.2, 0.02, and 2.0 yg/kg of venom respectively. 
(B) Short duration response. The arrows denote the infusion 
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concentration (Fig. 5, cross-hatched columns).
Figure 6 (open columns) is a composite of resistances to the three 
concentrations of venom from the first eight dogs. The abscissa 
represents venom concentration in yg/kg while the ordinate gives the 
percent resistance change from control, which was assigned the value 
of 100%. Control resistance represents the beginning steady state 
resistance. This means that a bar under the 100% mark represents 
vasodilation, and a bar over the 100% mark represents vasoconstriction. 
The change in resistance indicates that the venom produces vasodilation 
at the three concentrations tested. There does not appear to be a 
dose-response relationship from these collective data. However, closer 
analysis of the blood flow response to the venom revealed that there 
were two groups of dogs with two different dose-response relation­
ships: group 1 (Fig. 6, cross hatched columns) consisting of three dogs 
showed an inverse relationship between venom dose and change in vascular 
resistance. Here increases in venom concentration produced an increase 
in vascular resistance (i.e., less vasodilation). Group 2 consisting 
of five dogs (Fig. 6, solid columns) showed a proportional dose 
response relationship in which vascular resistance decreased (i.e., 
vasodilation increased) as the venom concentration was increased.
After separating the animals in this manner it was noted that the 
resting blood flows were strikingly different: 26.2 ± 4.4 ml and 62.1 
± 4.6 ml/min for group 1 and group 2 respectively. 
to have a significantly greater response to the venom than group 2, 
even after pretreatment with the blockers (p < 0.01).
Group 1 was noted
31
Fig. 5. Arterial and venous blood histamine content during Physalia
physalis venom infusion. Values represent histamine ng/ml of 
serum. The mean histamine value increases as the venom 
concentration increases. Columns represent mean histamine 
values ± SEM from a population of four animals. A = arterial 
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Fig. 6. Effect of Physalia physalis venom on the skeletal muscle 
vascular resistance of the canine hind limb. The ordinate 
gives the percent resistance change from control, which 
was assigned the value of 100%; therefore, a value under 
the 100% mark represents vasodilation. Open columns 
represent mean % of control resistance ± SEM with N = 8. 
Cross-hatched columns represent those animals having a low 
mean resting blood flow (26.2 ± 4.4 ml/min, N = 3). Solid 
columns represent the type of response associated with 
animals having a high mean resting blood flow (62.1 ±
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In Figure 7 we compared the action of the venom after the dogs 
had been treated with the five different blockers. Represented on the
abscissa are the actions of the venom after the dogs were first blocked 
with propranolol, phentolamine, atropine, tripelennamine and cimeti- 
dine, and sodium meclofenamate. The venom control is also represented 
on the abscissa. We found that only sodium meclofenamate significantly 
inhibited the venom induced vasodilation (p < 0.05). In addition, the 
venom produced a slight vasoconstriction when its vasodilatory action 
was blocked with sodium meclofenamate. The antihistamines also
appeared to slightly decrease the vasodilatory action of the venom, 
but this was not statistically significant (p > 0.05). The vaso­
dilation obtained with the venom in conjunction with propranolol , 
phentolamine, and atropine was not significantly different from the 
vasodilation produced by the control venom (p > 0.05).
In the second series of experiments we compared the action of 
Physalia venom alone, with that when given at the peak of the time- 
course response of the blood flow to norepinephrine, prostaglandin E-|, 
and histamine (Fig. 8). The peak changes in vascular resistance 
produced by the three vasoactive substances alone were also shown.
We chose these three vasoactive substances based on our observations
from the experiments on the first eight dogs. Since we observed that 
a prostaglandin synthesis inhibitor and the antihistamines affected 
the vasodilatory action of the venom, we postulated that perhaps there 
could be some interaction between the effect of the venom and prosta­
glandin or histamine. Norepinephrine was chosen because of the slight
36
Fig. 7. Effect of Physalia physalis venom on the skeletal muscle
vascular resistance of the canine hind limb after treatment 
with five pharmacologic blockers. Sodium meclofenamate 
was the only blocker to significantly inhibit the action 
of the venom (p < 0.05). The venom concentration used 
was 0.2 yg/kg as this was the dose that gave us the most 
consistent effect. Each column represents mean % of control 
resistance ± SEN, N =6, 7, 6, 7, 6, 6, from left to right. 
The steady state resistance before venom infusion was 















Fig. 8. Effect of Physalia physalis venom on the skeletal muscle 
vascular resistance of the canine hind limb when given 
at the peak of the time-course response of the blood 
flow of histamine, norepinephrine, and Prostaglandin E-j 
(cross-hatched columns). The effect of the three vaso­
active substances is shown for comparison (open columns).
The drug + venom induced vasodilations were not significantly 
different from the vasodilation produced by the venom alone. 
0.6 yg/kg of venom were used in these experiments. In the 
case of norepinephrine + venom, the control steady state 
resistance was taken at the maximal vasoconstriction 
produced by norepinephrine. N = 4 for each column.
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vasoconstriction observed when the action of the venom was blocked
with sodium meclofenamate. The vasodilatory effects produced by 
the venom-drug combination were not significantly different from the 
vasodilation produced by the venom control. It is noteworthy that in
each case the venom either significantly enhanced the dilatory effect
of the drugs or else totally reversed its constrictory effect.
When the left lumbar sympathetic chain was stimulated, there was
a slight increase in blood flow immediately followed by a sharp
decline. The vasoconstriction was maintained for about three minutes.
When the stimulation was terminated the blood flow increased slowly, 
producing a reactive hyperemia before returning to a level close to
the beginning steady state blood flow before stimulation. When the
venom was infused during the maximum vasoconstriction, the venom
transiently reversed but did not inhibit the sympathetically-induced
vasoconstriction. In the presence of cocaine, an inhibitor of neuronal 
uptake of catecholamine, the same procedure was attempted. The
results were similar. That is, a transient reversal but no inhibition
of the sympathetic induced vasoconstriction.
In vitro Experiments
The in vitro experiments were divided into four distinct sections: 
a norepinephrine (NE) dose response curve; a static tension (L) versus 
active tension curve; a venom dose response curve; and the effect of 
the pharmacological blocking agents on the vascular response to the
venom.
A representative time-course for the action of norepinephrine
41
(NE) in our in vitro preparation is shown in Figure 9. 
depicts contraction tension in g while the abscissa shows time in
The ordinate
As can be noted, the contraction tension obtained with NEminutes.
increased as the NE dose increased, until finally reaching a plateau.
It took only a few seconds for theThe effect of NE was very quick.
vessel to contract after the NE solution had been placed in the organ
Also, maximal contraction with any NE dose was obtained withinbath.
Low concentrations of NE usually did not maintainone to two minutes.
a steady state tension after reaching their maximal contractile
As the NE concentration was increased, the contracted state
-4was maintained longer, so that at very high concentrations (10 to 
_210 M) the vessel remained contracted at a steady state tension for
effect.
more than 60 minutes. Figure 10 shows the NE dose response curve 
obtained for the ring segments of rabbit femoral (n =7), renal 
(n = 9), central ear (n =8), and lingual arteries (n = 8). The 
abscissa depicts the NE concentration in mM per liter of bath solution, 
while the ordinate presents the percent of maximal constriction tension
From the NE dose response curves we calculated the
s were 1.6 x 10"^, 4.5 x 10"^,
produced by NE.
for each vessel. The NE ED^g 
-6 -68.0 x 10" , and 5.4 x 10 M for the femoral, renal, central ear, and
NE ED 70
lingual arteries respectively.
The above values (NE ED-^'s) were used in our preparation to 
obtain a static tension versus active tension curve as previously
described. Figure 11 shows a representative series of polygraph 
tracings depicting the process. As shown, the NE induced vaso-
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Fig. 9. Representative time-course polygraph tracing of the action 
of norepinephrine (NE) on the in vitro preparation. The 
arrows denote the NE concentration placed into the bath 
solution. After every NE dose the bath solution was 
changed. At high NE concentrations (10"5 to 10"2m), the 
vessels remained contracted at a steady state tension for 






















Fig. 10. Norepinephrine (NE) dose response curves for the in vitro 
femoral, renal, central ear, and lingual arterial ring 
segments. Each graph point represents mean ± SEN!. N = 7,
7, 8, and 8 for the femoral, renal, central ear, and lingual 
arterial segments respectively. From these curves the NE 
concentration which produced 70% of the maximal NE contrac­
tion (NE ED7q) was obtained and used to produce the static 
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Fig. 11. Representative time-course polygraph tracing demonstrating 
the effect of increasing static tension on the response to 
norepinephrine (NE) by the arterial ring segments.
47
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contraction tension increased as the starting static tension (L)
Also, the higher the starting static tension, the better 
the maintenance of a steady state contraction tension.
increased.
The static
tension versus active tension curves for the different arteries
The abscissa represents static tension in g.appear in Figure 12. 
while the ordinate gives the percent of maximal contraction tension
From these curves we selected the static tensionproduced by NE.
) at which the NE ED-^ produced its maximal active tension. 
The different L
(lmax
values were 1514.3 ± 59, 1 533.3 ± 152, 1044.4 ±max
109, and 1200.0 ± 166 mg for the femoral, renal, central ear, and
lingual arteries respectively.
The curves and values obtained in the first two sections were
used to produce the Portuguese Man-of-War venom dose response curves. 
However, the norepinephrine (NE) ED was used instead of the NE ED 7080
because the former concentration maintained a better steady state
In the case of the lingual artery, an (L )contraction tension. max
of 1000 mg was used, for the sake of simplicity. Figure 13 shows 
representative tracings of the Physalia venom's action. The effects
of the venom were varied depending on the vessel involved, 
cases, its action could be observed in seconds after the venom had
In some
Yet in others it took from one tobeen placed in the bath solution.
Also, in some vesselstwo minutes for the venom to produce its effects.
the maximal relaxation or vasodilation was obtained very fast, while
In every vessel tested the effect 
of the venom was to produce relaxation of the previously contracted
in others it took several minutes.
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Fig. 12. Static tension vs. active tension curves for the in vitro 
femoral, renal, central ear, and lingual arterial ring 
segments. Each graph point represents mean ± SEM. N = 7,
6, 9, and 10 for femoral, renal, central ear, and lingual 
arterial segments, respectively. From these curves the 
static tension at which the norepinephrine ED7q produced its 
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Fig. 13. Representative polygraph tracing of the action of Physalia 
venom in the in vitro arterial ring segments. The norepi­
nephrine (NE) EDqq was used. The effect of the venom was to 
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The relaxation was not a transient effect, but it remainedartery.
indefinitely in a steady state at a lower tension than that produced
In some preparations, especially those where the venom 
effect was very pronounced, the vasorelaxation appeared to be a
by the NE ED80*
transient reversal of the NE induced contraction. However, after a
steady state was reached the tension was always at a lower level than
that produced by NE.
Figure 14 gives the Physalia physalis venom dose response curves
obtained in our in vitro preparation for the four different arteries. 
The abscissa shows the venom concentration in yg/ml of bath solution. 
The ordinate depicts the percent from maximal relaxation produced
by the venom. The dose response curves follow a sigmoid
shape pattern. And as it can be observed, except for the lingual 
artery, all of the arteries achieve a plateau of 4.28 yg/ml. The 
venom concentrations which produced 50% of the venom's maximal effect 
(venom ED50) were 0.48, 0.26, 0.60, and 0.59 yg/ml of bath solution 
for the femoral , renal, central ear, and lingual arteries respectively.
Figure 15 compares the action of the venom after the vessels were 
treated with four different pharmacological blockers. Atropine, 
propranolol, and quinacrine did not appears to decrease the relaxing 
effect of the venom. The only blocker which significantly decreased 
the effect of Physalia venom was sodium meclofenamate. which blocked 
an average of sixty percent of its relaxing effect (p < 0.01)
The sodium salt of arachidonic acid was utilized to check for
proper blockade by sodium meclofenamate. However, instead of the
54
Fig. 14. Physalia physalis venom dose response curves for the in vitro 
femoral, renal, central ear, and lingual arterial ring seg­
ments. The abscissa shows the venom concentration in loga­
rithmic distribution. Each graph point represents mean ± SEM. 
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vasorelaxation expected with arachidonic acid, we consistently observed 
a contraction which was not blocked by sodium meclofenamate. Data 
points are available for perusal, and may be found in the appendices.
DISCUSSION
In vivo Experiments
Investigators suggested previously that Physalia physalis venom
acted by increasing the Na+ permeability across bioelectric mem-
35,36 We hypothesized that if the venom had the same effect 
in vascular smooth muscle, the result would be vasoconstriction perhaps 
followed by vasodilation as suggested by Garriot. 
however, show that the venom primarily produced vasodilation (Fig. 6).
branes.
13 Our experiments,
Out of eight dogs tested, only one reacted with vasoconstriction in 
all of the three venom concentrations used. This implies that the 
Portuguese Man-of-War venom has a biphasic effect in vascular smooth 
muscle; however, contrary to our expectation, vasodilation is the 
principal effect.
The venom-induced vasodilation was partially blocked by antihista­
mine, cimetidine and tripelennamine, and completely blocked by sodium 
meclofenamate, a prostaglandin synthesis inhibitor (Fig. 7). This
suggests that Portuguese Man-of-War venom produces its chief vaso-
dilatory action by stimulating the synthesis of prostaglandin. Prosta­
glandins have been found to play an important role in hemodynamics.
In 1976, Vane et aj_., isolated prostacyclin (PGI^), a vasodilator, from 
endothelial cells. This together with thromboxane (TxA2), a vaso­
constrictor, is believed to have an important role in regulating 
vascular tone. ^
lating the production of prostacyclin or some other vasodilatory prosta-
Our data suggest that Physalia venom might be stimu-
glandin such as PGA, PGD, PGE. Eight dogs were tested in this part of 
Dog No. 6 was left out because the venom producedthe experiment.
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vasoconstriction, an effect opposite to that being studied. Experi­
mental runs in which the agonists's effect were not completely 
abolished by the blockers were not included.
The vasodilatory action of the Portuguese Man-of-War venom itself 
was not affected by histamine nor PGE-j when these were injected simul­
taneously (Fig. 8). It is noteworthy that our vascular preparation 
was not maximally dilated with 0.6 yg/kg of venom since higher concen­
trations produced even greater reductions in vascular resistance. In 
each case the venom either significantly enhanced the vasodilatory 
effect of the drugs or transiently reversed its vasoconstrictory 
effect; however, the dilatory compound induced by the venom was never 
greater than the dilation produced by the venom alone. Our preliminary
conclusion is that there is no synergistic, additive, nor antagonistic 
action between these three drugs and the venom.
The purpose for using the venom in conjunction with sympathetic 
stimulation was to investigate the possibility that the venom exerts 
its vascular effects via inhibition of the sympathetic nervous system. 
If the venom were interfering with adrenergic receptor sensitivity to 
NE, or with the release of NE from the sympathetic nerve endings, we 
would have expected a reversal or inhibition of the sympathetic
If it were to increase the uptake of NE into 
the sympathetic nerve endings, we would have expected the venom to 
interfere with the exaggeration of sympathetic vasoconstriction caused 
by cocaine, an inhibitor of neuronal NE uptake, 
a transient reversal of sympathetic vasoconstriction with Physalia
induced vasoconstriction.
Since we only observed
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venom without change in cocaine-mediated enhancement, we concluded that 
the venom does not produce its primary vasodilation by interfering with 
sympathetic transmitter release nor uptake.
One of our most interesting findings was the presence of two types 
of venom-induced effects, in terms of the kinetics of blood flow (Fig. 
4) and the dose response of vasodilation (Fig. 6). The long-duration 
venom-induced blood flow response (Fig. 4A) was elicited from those 
dogs with a low resting blood flow rate, while the short-duration 
response (Fig. 4B) was found exclusively in those dogs with a high 
resting blood flow rate. Likewise, dogs presenting an inverse dose- 
response curve (Fig. 6, cross-hatched columns) had low resting blood 
flow rates while those giving a proportional dose-response curve 
(Fig. 6, solid columns) had high resting blood flow rates. Care was 
taken to avoid contamination of the isolated skeletal muscle vascu­
lature with skin venous blood; however, the presence of two populations 
of dogs (high and low resting blood flow rates) might suggest collateral
circulation between skeletal muscle and skin. The response from dogs
with low resting blood flow possibly represent nearly pure skeletal 
muscle blood flow while that from dogs with high resting blood flow 
represent a mixture of skeletal muscle and skin blood flow, 
different dose-response relationships might suggest that the vascular 
beds of skin and skeletal muscle lie on different portions of the true
The two
venom dose-response curve, perhaps due to differing sensitivities of
these tissues to the venom; that is, muscle vasculature is more
sensitive to the venom than skin vasculature. With increasing venom
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concentration, skin vasculature responds with increasing vasodilation,
while skeletal muscle vasculature responds with maximal vasodilation
at 0.02 yg/kg and with lesser response at greater venom concentrations. 
This implies that the effect of the venom peaks at about 0.02 yg/kg
concentration in skeletal muscle vasculature.
Measurement of histamine in the arterial and venous blood, before
and after venom infusion, showed a significant increase in histamine
content of the venous blood. The histamine concentration appeared to 
follow a dose-response pattern (Fig. 5). This supports the idea that
the vasodilatory action of the venom might be due, at least in part,
to histamine release, perhaps from mast cells, as suggested by the
53,171iterature.
From our in vivo data we conclude that the Physalia physalis 
venom is a vasodilatory agent in canine skeletal muscle vasculature.
The mechanism of the venom's action does not seem to involve primary 
interaction with muscarinic, nor alpha and beta adrenergic receptors, 
nor does it appear to irreversibly affect adrenergic receptor sensi-
Rather, our data suggest that the venom's action is principallytivity.
mediated through the stimulation of prostaglandin synthesis.
In vitro Experiments
We evaluated the action of the Physalia physalis venom by a direct 
method of recording tension in the wall of small blood vessels, as
Our intention was to study, in andescribed earlier in this study. 
in vitro setting, the effects and mode of action of Portuguese Man- 
of-War venom on vascular tissue, and to compare the results with
61
those of our in vivo experiments.
The arterial ring segment for recording wall tension has been used
6,24,44successfully by many researchers. It allows the study not only 
of the pharmacology, but also of the wall dynamics of blood vessels
100 ym i.d. and smaller. . The arterial ring segments are easier to
prepare and can produce up to twice the maximal force to norepinephrine
24(NE) as compared to spiral strips of equal weight.
We chose to use rabbits for economical reasons. We did not use
rats because of the known anomalous distribution of various receptors
in their vascular bed as compared to other laboratory animals. Only
adult male California rabbits were used in order to avoid any possible
intersexual as well as intra-strain differences.
The Portuguese Man-of-War venom dose concentrations used in the 
in vitro experiments had a greater range than the concentrations used
in the in vivo study. The venom doses in the dog experiments were 
limited by the large amount of venom necessary to reach high doses and 
by short supply of the venom. The venom doses used in our in vitro
preparation were comparable to those used in the dog experiments. The 
starting static tension of 300 mg approximates the tension that the 
wall of a small blood vessel (500 ym i.d.) experiences at a blood 
pressure of 100 mm Hg. For the sake of simplicity, the same starting 
static tension was used for all of the arterial ring segments.
The effective dose which produced 70% of the maximal norepin­
ephrine contraction (NE ED^q) and the static tension for maximum 
active force (L max) were necessary for optimizing the conditions of
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the arterial ring segments for the testing of the venom. Since we found 
in our previous study that the venom produced vasodilation in vivo; we
needed to have a contracted vessel segment to appreciate the venom's
effects. For this we chose NE as our contracting agent. We also 
attempted to produce contraction electrically by stimulating the 
arterial ring segments with bipolar field electrodes. For unknown
reasons we were unable to induce contraction with this method. The
NE ED^q's were used to produce the static tension versus active tension
s were used in the testing of the venom 
because they produced a more stable steady state contraction tension 
for a longer period. Minimal fading of the NE-induced contraction
curves although the NE ED80
was vital as a steady base line was needed to accurately measure the 
venom-induced relaxation, particularly at very low venom concentrations.
The norepinephrine (NE) dose response curves that we obtained
24,44were very similar to those obtained by other investigators.
NE doses frequently caused relaxation, while larger concentrations
Smal 1
produced contraction. These findings are similar to those observed
c
by Bevan and Osher. At very high NE concentrations the contraction 
tension decreased instead of maintaining a maximum steady state. This
44appears to be typical of the NE dose response curve in vessels.
The static tension for maximal active force (L
44vessel, as shown by Price et al., 
arterial ring segments from dogs reacted optimally to a NE challenge 
when the static tension was at a critical value.
) for eachmax
is very important. In his study,
The variations in vascular relaxation observed with the venom
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can be explained by possible differences in the preparation of the 
arterial ring segments. Although care was taken to treat all the 
vascular tissues alike, some vessels were invariably cleaned better
than others. Thus the variations in time of onset and slope of
relaxation could be due to the time it took the venom to traverse
varying amounts of nonvascular tissue to reach sensitive areas in the 
The end result of the venom's action, however, was relaxationvessels.
of the NE-induced contraction.
The venom-induced vasodilation observed in the dog experiments
was transient in nature, lasting several minutes at best. The
relaxation in the in vitro experiments was not a transient effect, but 
remained indefinitely in a steady state at a tension lower than that
produced by the NE ED This difference could be due to the nature80*'
of the binding of the relaxing factor in the venom with the receptor
site in the vascular bed. Perhaps the binding is not very strong, 
resulting in a transient effect in vivo. On the other hand, in an 
organ bath, the venom is in contact with the vascular tissue until 
the bath solution is changed. Another explanation is the possible 
presence of substances in the blood which denature the venom, 
shortening its half life, and thus producing a transient vasodilation
in vivo.
The four types of arterial ring segments were chosen to compare 
possible response differences in various vascular beds. Slight 
variations in response to the venom can be detected in the four dose 
response curves (Fig. 14). The differences are evident in the venom
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effective dose required to produce 50% of the maximal relaxation.
The venom ED^g for the femoral and renal arteries appear to be 
lower than that for the central ear and lingual arteries. This would 
indicate that the femoral and renal arteries are more sensitive to the
relaxing effect of the venom. Another possible explanation for the 
grouping of the venom ED^g's is the variation in nonvascular tissue 
on the adventitial surface of the arterial segments. The lingual and 
central ear arteries had considerably more extraneous tissue which may 
have interfered with the venom's action. Although these differences 
may represent a trend, the average venom ED5q values when calculated 
from each experimental trial for the various vessels are not statisti­
cally significant, and no definite conclusions can be made (See 
Appendix B).
The concentration of blocking agents and agonists in our experi-
2,15,45ments were guided by the doses used by other investigators, 
although the concentrations usually had to be titrated in each of the
experiments for best results. Such was the case especially of 
propranolol, quinacrine and sodium meclofenamate. In the case of 
quinacrine, we had no available method to test the completeness of 
its blocking action (no assay for measuring phosphlipase A£ activity 
was available). Thus, in order to insure complete blockade of the 
phospholipase activity, we gradually increased the concentration 
until the vessel showed signs of injury, as demonstrated by a decreased 
response to norepinephrine. The venom was tested after every incubation 
period with a larger dose of quinacrine. In each case, the dose given
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prior to vessel damage was considered to be the blocking concentration. 
The agonist used to test the prostaglandin synthesis inhibitor
was sodium arachidonate. This has been shown to be the substrate
used by cyclooxygenase (prostaglandin synthetase) to produce prosta­
glandins. When infused into the circulation arachidonate usually
produces hypotension and vasodilation in vivo and vascular relaxation
13,45 The actions of arachidonic acid can be blocked with
8,16,54
in vitro.
sodium meclofenamate and other cyclooxygenase inhibitors.
Contrary to our expectations considering the available literature, the 
sodium arachidonate produced further vasocontraction of the NE 
contracted arterial ring segments. This vasocontraction was not 
blocked by sodium meclofenamate. We have no good explanation for this
observation, except to suggest that perhaps some other metabol ite of 
arachidonic acid not blocked by meclofenamate is being produced. The 
leukotrienes (LT), previously known as Slow Reacting Substance of 
Anaphylaxis (SRS-A), are well known metabolites of arachidonic acid
(Fig. 16). These are able to constrict bronchial smooth muscle and
41 ,25,49some also have a leukocyte chemotaxic effect. LTC^ constricts
coronary arteries so strongly that some researchers speculate that it is
41involved in the production of Prinzmetal's angina, 
vasoconstriction induced by leukotrienes is a direct or indirect effect
Whether the
is not clearly understood. Sirois P. et al have shown some evidence•»
that increases in mean arterial pressure induced by intravenous leuko-
48trienes may be mediated by prostaglandins. However, Weinchman et
al., found evidences of direct and indirect leukotriene mediated
66
54smooth muscle constriction. It is, therefore, possible that leuko-
trienes might be involved in the vasoconstriction of the arterial ring 
segments observed with arachidonic acid.
In the case of sodium meclofenamate, information in the available
literature as to its use in vitro was conflicting, and complicated 
its use and choice of effective in vitro blocking concentration. 
Therefore, titration was essential to establish an optimal blocking 
dose for the in vitro preparation. We found that the effective block­
ing dose was very close to the lethal dose, so that care was necessary 
to avoid damage to the vessels.
Sodium meclofenamate was the only blocker which significantly 
decreased the Physalia venom-induced relaxation (Fig. 15). Propranolol , 
atropine, and quinacrine did not decrease the action of the venom. In 
the in vitro study, an average of 60% of the venom's effect was blocked, 
compared to 100% in the dog experiments (Fig. 7). This probably 
indicates partial blockade in some of the arterial ring segments and 
stresses the difficulty we encountered in finding an effective sodium 
meclofenamate blocking dose. However, in some of the experimental 
trials it was clearly seen that 100% of the venom's effect had been 
blocked. Therefore our in vivo and in vitro data suggest that Physalia 
physalis venom does not interact with muscarinic nor a and 3
adrenergic receptors to produce vasorelaxation. Further, it appears
that its vasorelaxation is mediated via the stimulation of prosta­
glandin synthesis.
Figure 16 shows the major metabolic transformations of arachidonic
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Fig. 15. Effect of Physalis venom after pretreatment of the in vitro 
arterial ring segments with the pharmacological blockers. 
Sodium meclofenamate significantly inhibited the action of 
the venom (p < 0.01). Each column represents mean % of 
venom control relaxation ± SEM. N = 6, 10, 7, and 18 for 




















Fig. 16. Major metabolic transformations of arachidonic acid. Broken 
arrows indicate nonenzymatic reactions. Figure was taken 
from Cardiovascular Pharmacology of the Prostaglandins,

























acid. The metabolism of arachidonic acid takes place in the free fatty 
acid itself. Yet the majority of fatty acids in tissue are present 
in the esterified form as phospholipids of cell membranes. Thus the 
rate-limiting step in the production of prostaglandins and related
compounds is the enzymatic liberation of arachidonic acid by phosph- 
1 ipase A2» or by the combined action of phospholipase C and diglyceride 
1ipase.22
Quinacrine historically has been used as an antimalarial agent.
However, our interest is in its ability to inhibit the activity of
15,46phospholipase ^ and the production of prostaglandins, 
that quinacrine did not affect the action of the venom indicates that
The fact
the venom does not stimulate prostaglandin production by increasing 
substrate availability via the stimulation of phospholipase activity. 
This is contrary to the observations made by Shier, 
show that Portuguese Man-of-War venom activates high levels of membrane 
phospholipase in cultured mouse fibroblasts, 
support this mechanism for vascular smooth muscle. However, more 
experimentation with such phosphlipase A^ inhibitors as glucocorticoids 
and chloroquine should be performed before a definitive conclusion is 
reached.
47 He was able to
Our data do not
When Physalia physalis venom was administered to the arterial ring 
segments after being incubated with propranolol, atropine, and quina­
crine, the observed relaxations were greater than that produced by the 
venom control (Fig. 15). However, the difference in relaxations were
not statistically significant. This trend may indicate an enhancement
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of the venom's action by the various blockers. However, some of these
agents are quite toxic, so that what is most likely observed is the
deleterious effect of the blockers on the smooth muscle contractile
apparatus. This would accentuate the relaxing mechanism stimulated
by the venom, resulting in greater vasorelaxation.
Much research has been done on the effect of prostaglandins in 
smooth muscle, yet not all that is to be learned has been uncovered.
In light of our experimental observations we can attempt to narrow down 
the possible prostaglandin species responsible for the vasorelaxation
induced by the Portuguese Man-of-War venom.
Vascular smooth muscle is considered to have the conventional
contractile apparatus composed of thin and thick filaments. The thin 
filaments in smooth muscle contain actin and tropomyosin subunits but, 
unlike striated muscle, the presence of troponin has not been 
established. Like skeletal muscle, smooth mucle contractility is 
believed to be regulated by the concentration of intracellular Ca++. 
Whether the intracellular Ca++ is sufficient for smooth muscle
contraction or whether extracellular Ca++ is required has not yet
Several investigators have suggested that prosta-21been determined.
glandins produce their vasorelaxation by interfering with Ca++ availa­
bility to the contractile apparatus.^ Investigators have yet to reach 
a consensus but most agree that prostaglandins produce their vaso­
dilation by a direct mechanism on the vascular smooth muscle, perhaps
by interference with Ca++ flux.
Blood vessels have been observed to produce prostaglandins both
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A variety of stimuli such as arachidonic acid,in vivo and in vitro.
enzymes, vasoactive peptides, ionophores, hypoxia, decreased tonicity, 
mechanical stimulation, and nerve stimulation are able to elicit de
novo prostaglandin synthesis from vessels. Synthesis of prostaglandins
in different layers of the arterial wall has been demonstrated by 
40Moncada et al. In our jji vi tro preparation the Physa! ia venom was
able to come in contact with both the luminal as well as the adventi­
tial surface of the arterial segments. Thus it is possible that both 
surfaces contribute in the prostaglandin synthesis induced by the venom
since endothelium, smooth muscle and fibroblasts have the capacity to
produce prostaglandins.
Prostacyclin (PG^) is the major metabolite of arachidonic acid
14,19,38 The vascularsynthesized in vessels jji vivo and vn vitro.
endothelium produces most of the PGI^, as compared to the medial and 
adventitial layers.^ PG^ is a powerful relaxating agent of smooth 
muscle in vitro and in vivo. Similar observations have been made on
the action of PGE2. At one time PGE2 was thought to be the main 
vascular metabolite of arachidonic acid. It has been postulated that 
this substance could be an endogenous regulator of adrenergic neuro- 
transmission since stimulation of sympathetic nerves has been found 
to be a powerful stimulus for prostaglandin synthesis. In addition, 
PGE2 reduces the output of norepinephrine from nerve endings and 
diminishes the pressor effects of exogenous norepinephrine. Such
findings prompted Hedqvist to propose that prostaglandins of the E 
series serve as feedback inhibition to adrenergic transmission by
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decreasing presynaptic norepinephrine release and by decreasing its
4,33pressor effect in vascular smooth muscle.
In our in vivo experiments we concluded that the venom did not 
interfere with the effect of norepinephrine (NE) or with sympathetic 
nervous transmission. The only change observed was a transient 
reversal of the vasoconstriction induced by exogenous NE, and 
sympathetic stimulation. In the in vitro experiments, the venom- 
induced vasorelaxation was observed to last 30 minutes and longer.
This fits with the action of a stable compound such as PGE2, as 
compared to PGI^ which has a half life of 7 minutes at 37°C. However, 
constant production of PGI^ could foreseeably elicit the same effect, 
assuming that a heat labile substance such as Physalia venom remains 
active at 37°C for up to 30 minutes. It is possible that Physalia
physalis venom is stimulating the biosynthesis of an agent with 
prostacyclin-1 ike activity.
Sodium meclofenamate is a non-steroidal anti inflammatory agent 
with analgesic and antipyretic properties. Its molecular mode of 
action has not been elucidated; however, in animal studies meclo­
fenamate inhibits prostaglandin synthesis by blocking the action of 
cyclooxygenase. Meclofenamate has also been shown to compete for 
binding at the prostaglandin receptor site in the target tissues. 
Therefore, it is possible that the venom is producing its vasorelaxation 
via the stimulation of cyclooxygenase and/or affecting the prostaglandin
1
sensitive areas in the vascular smooth muscle.
SUMMARY AND CONCLUSIONS
We studies the effects of Portuguese Man-of-War venom in the
in vivo canine skeletal muscle vascular bed, and in the in vitro
rabbit arterial ring segments. The venom produced relaxation of the
vascular smooth muscle. Slight vasoconstriction occurred in some of 
the in vivo experiments, but only after prostaglandin synthesis block­
ade.
Some differences in the venom-induced vasodilation in the two
systems were evident. In the in vivo preparation, the vasodilation 
was transient, lasting at most a few minutes. Vascular segments in 
vitro, on the other hand, responded with a sustained steady state
relaxation, which lasted up to 30 minutes or as long as the bath 
solution was not changed. We postulated that this difference was due
to weak venom-receptor binding and/or the effect of blood or blood
products on the venom.
In the dog experiments we found that the vascular sensitivity to 
the venom varied with the starting resting blood flow level. When the 
resting blood flow was high, the venom-induced vasodilation had a short
duration and a proportional dose-response curve. When low, the venom- 
induced vasorelaxation lasted longer and the dose-response curve had 
an inverse relationship. We postulated that the low and high resting 
blood flow levels in the different animals represented skeletal muscle 
and skeletal muscle plus skin blood flow rates respectively, and that 
the difference in response of the two groups of dogs reflected different




The in vitro venom dose response curves revealed that vessels of
However, the1arger caliber tended to have a lower venom ED 
difference was not statistically significant. Contrary to our in 
vivo observations, no qualitative differences in the venom-induced 
vasodilation were noticed in vessels from superficial and skeletal
50*
muscle vascular beds of the rabbits.
Sodium meclofenamate inhibited the venom-induced vascular
relaxation both in vivo and in vitro. Propranolol, phentolamine, 
atropine, antihistamine, and quinacrine did not significantly change 
the effectiveness of the venom. The Portuguese Man-of-War venom did 
not interfere with adrenergic nerve transmission nor with exogenous 
norepinephrine infusion.
From our data we conclude that Physalia physalis venom is a vaso- 
dilatory agent of vascular tissue. The mechanism of the venom's 
action does not seem to involve primary interaction with muscarinic, 
nor alpha and beta adrenergic receptors, nor does it appear to irre­
versibly affect adrenergic receptor sensitivity. Rather, our data 
suggest that the vasodilatory action of the venom is mediated through 
the stimulation of prostaglandin synthesis by way of cyclooxygenase 
pathway and/or stimulation of the prostaglandin receptors in vascular 
smooth muscle. At this point our data does not support the stimula­
tion of phospholipase by the venom as a mechanism of action.
BIBLIOGRAPHY
1. Angel:, J. E. (publisher): Physicians' Desk Reference. 37th edition.
Medical Economics Company, Inc., Grade!!, N. J., !983.
2. Adams, P. R. and Feltz, A.: Quinacrine (mepacrine) action at the
frog end-plate. Journal of Physiology (London) 306:261-281, 
1980.
3. Altman, P. L. and Dittmer, D. S.: Biology Data Book. Federation 
of American Societies for Experimental Biology. Washington, 
D.C., 1964.
4. Armstrong, J. M.: Prostaglandins: pre- and post-junctional modu­
lation of adrenergic nerve function. _In Cardiovascular 
Pharmacology of the Prostaglandins, ed. by A. G. Herman, P. M. 
Vanhoutte, H. Denolin and A. Goossens, pp. 51-64, Raven Press, 
New York, 1982.
Cardiovascular Physiology.Berne, R. M. and Levy, M. N. 
St. Louis, Mosby, 1977.
5.
6. Bevan, J. A. and Osher, J. V.: A direct method for recording tension 
changes in the wall of small blood vessels in vitro. Agents 
and Actions 2:257-260, 1972.
7. Biller, H., Schachtschabel, D. 0., Leising, H. B., Pfab, R. and
Heb, F.: Intensification of the inhibitory effects of x-rays 
on the growth of Ehrlich ascites tumor cells in monolayer 
culture by quinacrine. Strahlentherapie 156:547-553, 1980.
8. Bult, H. and Herman, A. G.: Prostaglandins and circulatory shock.
In Cardiovascular Pharmacology of the Prostaglandins, ed. by 
A. G. Herman, P. M. Vanhoutte, H. Denolin and A. Goossens, 
pp. 315-326, Raven Press, New York, 1982.
9. Burnett, J. W., Cal ton, G. J.: The chemistry and toxicology of
some venomous pelagic coelenterates. Toxicon 15:177-196, 1977.
10. Burnett, J. W., Calton, G. J., Meier, H. and Kaplan, A. P.:
Mediators present in the nematocyst venoms of the Sea Nettle, 
Sea Wasp and Portuguese man-0'war. Comparative Biochemistry 
and Physiology 510:153-156, 1975.
Cameron, S. G. and Bohr, D. F.: Effects of PGE-|, E^, A-| and F^ 





12. Cormier, S. M., Hessinger, D. A.: Cnidocil apparatus: sensory
receptor of Physalia nematocysts. Journal of U1trastructure 
Research 72:13-19, 1980.
13. Deby, C., Van-Caneghem, P. and Bacq, Z. M.: Arachidonate induced 
hypotension and haptoglobin plasma level in the rabbit. 
Biochemical Pharmacology 27:613-615, 1978.
14. DeDeckere, E. A. M., Nugteren, D. M. and Ten-hoor, F.: Prostacyclin 
is major prostaglandin released from isolated perfused rabbit 
and rat heart. Nature (London) 268:160-163, 1977.
15. Feverstein, G., Dimicco, J. A. and Kopin, I. J.: Effect of indo-
methacin and quinacrine on blood pressure and plasma catechol­
amines in endotoxic shock. Circulatory Shock 7(2):196, 1980.
16. Fitzpatrick, T. M., Johnson, NL, Kot, P. A., Ramwell, P. W. and 
Rose, J. C.: Vasoconstrictor response to arachidonic acid in 
the isolated hind limb of the dog. British Journal of 
Pharmacology 59:269-273, 1977.
17. Flowers, L. A. and Hessinger, D. A.: Mast cell histamine release
induced by Portuguese Man-of-War (Physalia) venom. Biochemical 
and Biophysical Research Communications 103:1083-1091, 1981.
18. Garriott, J. C. and Lane, C. E.: Some autonomic effects of Physalia 
toxin. Toxicon 6:281-286, 1969.
19. Gryglwski, R. J Korbut, R. and Ocetkiewicz, A.: Generation of 
prostacyclin by lungs in vivo and its release into the arterial 
circulation. Nature (London) 273:765-767, 1978.
• 5
20. Guyton, A. C.: Textbook of Medical Physiology, sixth edition, W. B.
Saunders Company, Philadelphia, 1981.
21. Hartshorne, D. J.: The contractile apparatus of smooth muscle and
its regulation by calcium. Jji Vascular smooth muscle: meta­
bolic, ionic, and contractile mechanisms, pp. 135-155, M. F. 
Crass III and C. D. Barnes (eds.). Academic Press, Inc.,
New York, 1982.
22. Hastings, S. G., Larsen, J. B. and Lane, C. E.: Effects of Nemato- 
cyst toxin of Physalia physalis (Portuguese Man-of-War) on the 
canine cardiovascular system. Proceedings of the Society for 
Experimental Biology and Medicine 125:41-45, 1967.
23. Herman, A. G.: Introductory remarks about the nomenclature of 
prostaglandins and their biosynthesis and metabolism. In 
Cardiovascular pharmacology of the prostaglandins, ed. by 
A. G. Herman, P. M. Vanhoutte, H. Denolin and A. Goossens, 
pp. 1-5, Raven Press, New York, 1982.
79
24. Hooker, C. S., Calkins, P. J. and Fleisch, J. H.: On the measure­
ment of Vascular and respiratory smooth muscle response in 
vitro. Blood Vessels 14:1-11 , 1977.
25. Krell, R. D., Osborn, R., Vickery, L., Falcone, K., O'Donnell, M 
Gleason, J., Kinzig, C. and Bryan, D.: Contraction of 
isolated airway smooth muscle by synthetic leukotrienes C^, 
and D,. Prostaglandins 22:387-409, 1981.
• 5
4
26. Lane, C. E., Pringle, E. and Bergere, A. M.: Amino acids in extra­
cellular fluids of Physalia physalis and Aurelia Aurita. 
Comparative Biochemistry and Physiology 15:259-262, 1965.
27. Lane, C. E.: The Portuguese Man-of-War. 
158-168, 1960.
Scientific American 202:
Lane, C. E.: The toxin of Physalia nematocysts. Annals of the 
New York Academy of Science 90:742-750, 1960.
28.
Lane, C. E. and Dodge, E.: The toxicity of Physalia nematocyst. 
Biological Bulletin (Woods Hole) 115:219-226, 1958.
29.
30. Lane, C. E.: Some cardiac effects of Physalia toxin. 
Proceedings 24:234, 1965.
Federation
31. Lane, C. E. and Larsen, J. B.: Some effects of the toxin of
Physalia physalis on the heart of the land crab, Cardisoma 
Guanhumi (Latreille). Toxicon 3:59-71, 1965.
32. Lane, C. E.: Recent observations on the pharmacology of Physalia
toxin. _In Animal Toxins, F. E. Russell and P. R. Saunders 
(eds.), pp. 131-136, Pergamon, Oxford, 1967.
33. Langer, S. Z., Enero, M. A., Adler-Graschinsky, E., Dubocovich,
M. L. and Giorgi, 0.: Regulation of transmitter release. _In 
Vascular Neuroeffector Mechanisms, Second International 
Symposium, Odense, pp. 112-122, Karger, Basel, 1975.
34. Larsen, J. B. and Lane, C. E.: Some effects of Physalia physalis
toxin on the cardiovascular system of the rat. Toxicon 4: 
199-203, 1966.
35. Larsen, J. B. and Lane, C. E.: Direct action of Physal ia toxin on 
frog nerve and muscle. Toxicon 8:21-23, 1970.
36. Larsen, J. B. and Lane, C. E.: Some effects of Physalia physalis 
toxin on active Na+ transport across frog skin. Comparative 
Biochemistry and Physiology 34:333-338, 1970.
80
37. Lin, D. C. and Hessinger, D. A.: Inhibitory action of red cell
membrane proteins on the hemolytic action of Portuguese Man- 
of-War venom. Federation Proceedings 39(3):740, 1981
38. Messina, E. J., Weiner, R. and Kaley, G.: Prostaglandins and local 
circulatory control. Federation Proceedings 35:2367-2375, 
1976.
39. Moncada, S., Gryglewski, R Buting, S. and Vane, J. R.: An 
enzyme isolated from arteries transforms prostaglandin 
endoperoxides to an unstable substance that inhibits platelet 
aggregation. Nature (London) 263:663, 1976.
• 3
40. Moncada, S., Herman, A. G Higgs, E. A. and Vane, J. R.: 
Differential formation of prostacyclin (PGX or PGI^) by 
layers of the arterial wall. An explanation for the anti­
thrombotic properties of vascular endothelium. Thrombosis 
Research 11:323-344, 1977.
• 3
41. Marx, J. L.: The leukotrienes in allergy and inflammation. 
Science (Washington, D.C.) 215:1380-1383, 1982.
42. Neeman, I., Calton, G. J. and Burnett, J. W.: Purification and 
characterization of the endonuclease present in Physalia 
physalis venom, Comparative Biochemistry and Physiology 
676:155-158, 1 980.
43. Pantin, C. F. A. The excitation of nematocysts. Journal of 
Experimental Biology 19(3):294-310, 1942.
44. Price, J. M., David, D. L. and Knauss, E. B.: Length-dependent
sensitivity in vascular smooth muscle. American Journal of 
Physiology 241 (Heart Circ. Physiol. 10) H557-H563, 1981.
45. Quirion, R., Rioux, F. and Regoli, D.: Effect of arachidonic
acid and indomethacin on the in vivo release of prosta­
glandins by aortic strips of spontaneously hypertensive 
rats. Canadian Journal of Physiology and Pharmacology 
56(3):509-511, 1978.
46. Salmon, J. A.: Inhibition of arachidonic acid metabolism. J_n
Cardiovascular Pharmacology of the Prostaglandins, ed. by 
A. G. Herman, P. M. Vanhoutte, H. Denolin and A. Goossens, 
pp. 7-22, Raven Press, New York, 1982.
Shier, W. T.: Activation of self-destruction as a mechanism of 
action for cytolytic tgxins. _In Natural Toxins, ed. by 
D. Eaker and T. Wadstrom, pp. 193-200, Pergamon Press, 
Oxford and New York, 1980.
47.
81
48. Sirois, P., Kerouac, R., Roy, S., Borgeat, P., Picard, $., and 
Rioux, F.: In vivo effects of leukotriene B,, C,, and D.. 
Evidence that changes in blood pressure are^mediated by4 
prostaglandins. Prostaglandins & Medicine 7:363-373, 1981.
49. Smedegard, G., Hedqvist, P., Dahlen, S., Revenas, B., Hammarstrom,
S. and Samuelsson, B.: Leukotriene C4 affects pulmonary and 
cardiovascular deynamics in monkey. Nature 295:327-329, 1982.
50. Stillway, L. W.: Lipid classes of selected anatomical structures
from the Portuguese Man-of-War Physalia physalis. Comparative 
Biochemistry and Physiology 63B:147-149, 1978.
51. Stillway, L. W. and Lane, C. E.: Phospholipase in the Nematocyst
toxin of Physalia physalis. lexicon 9:193-195, 1971
52. Tamkun, M. M. and Hessinger, D* A.: Isolation and partial
characterization of a hemolytic and toxic protein from the 
nematocyst venom of the Portuguese Man-of-War, Physalia 
physalis. Biochimica et Biophysica Acta 667:87-98, 1981.
53. Uvnas, B.: Mechanism of action of a histamine-liberating principle
in jellyfish (Cyanea capillata). Annals New York Academy of 
Science 90:751-759, 1960.
Holden, D. A54. Weichman, B. M., Muccitelli, R. M., Osborn, R. R
Gleason, J. G. and Wasserman, M. A.: Jn vitro and jji vivo 
mechanisms of leukotriene-mediated bronchoconstriction in the 
guinea pig. Journal of Pharmacology and Experimental Thera­
peutics 222:202-208, 1982.
• 5 • 5
APPENDIX A: Data for the in vivo experiments (SAw Series)
A
In Vivo Data for Physalia Venom Dose Response (SA Series) *
A
Venom Fern a 
yg/kg BP
Fern v B1 F Resis S Fern S Fern B1 F Resis % of SS








59.2 2.04 22.4 5.769.0 35.4
17.40.20 3.15 11.036.2 59.123.3 5.33
12.52.00 14.1 14.3 20.08.69 138.36.28
SA2
85.9 1.70.02 19.8 4.26 1.1 11.8 8.0496.0 53.0
1.50.20 93.8 17.2 94.8 1.3 14.65.38 83.86.42








0.02 54.8 1.804.4 54.5 99.4
1.330.20 6.8 75.0 4.0 52.5 2.03 65.5











71.0 1.48 1.360.20 2.3 2.3 79.8








0.02 32.9 3.28 0.6 3.80 86.329.0
1.1 49.3 0.40.20 35.6 3.152.22 70.6





1.69 101.2 41.00.02 59.4 2.46 68.70.8 0.2
2.33 110.7
115.9
0.20 39.6 0.0 42.40.0 2.58 98.8










0.02 8.5 63.3 2.75 8.6 64.4 2.68
0.20 8.0 64.6 2.78 8.5 66.9
7.8 76.3
2.66








1.710.02 69.68.0 72.0 6.2 96.5
10.811.3 81.6 1.47 1.580.20 76.9 93.0
1.25 11.5 1.4112.02.00 85.6 77.5 88.6
* Blood pressure (BP) is expressed in mmHg; Vascular resistance 
(Resis) is expressed in peripheral resistane units (pru); Blood 
Flow (B1 F) is expressed in ml/min. (S) denotes steady state and/ 
or saline effect base line.
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In Vivo Physalia physalis Venom Effect Data*
Experiments (SAX Series)
Venom SAT SA2 SA3 SA4 SA5 SA6 SA7 SA8 Mean ± SEM 
yg/kg
68.7 102.6 96.5 80.335.4 53.0 99.4 100.7 86.3 8.90.02
0.20 59.1 83.8 65.5 109.1 70.6 110.7 104.5 93.0 87.1 7.2
86.8 41.4138.3 71.9 50.9 115.9 82.1 88.6 84.5 11.22.00
* Values represent percent resistance change from control resistance, 
which was assigned a value of 100%.
Date for the Venom Dose Response in Animals Having Low and High Resting 
Blood Flows*
A) Low Resting Blood Flow:
SA1 SA2 SA6 Mean ± SEMVenom
yg/kg
52.4 9.60.02 35.4 53.0 68.7
0.20 59.1 83.8 110.7 84.5 14.9
2.00 138.3 71.9 115.9 108.7 19.5
B) High Resting Blood Flow:
SA7 SA8 Mean ± SEMSA3 SA4 SA5Venom
yg/kg
97.1 2.999.4 100.7 86.3 102.6 96.50.02
104.5 93.0 88.5 8.865.5 109.0 70.60.20
2.00 50.9 86.8 41.4 82.1 88.5 70.0 9.9
* Values represent percent resistance change from control resistance, 
which was assigned a value of 100%. Low blood flow = 26.2 ± 4.4 ml/ 
min, and high blood flow = 62.1 ± 4.6 ml/min. Arterial blood pressure 
was 111.4 ± 6.6 mmHg and 127.8 ± 7.8 mmHg for the low and high blood 
rates respectively.
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Data for the in vivo Effect of the Venom After Treatment with the 
Pharmacological Blockers.*
Experiments (SAX Series)
SA2 SA3 SA4 SA5 SA6 SA7 SA8 Mean ± SEMBlocker SA1




67.7 89.1 66.2 93.0 67.5 98.7 88.0 81.4 5.2
88.4 71.2Atropine 54.7 89.7 98.6 93.8 82.7 6.8
Antihis- 61.2 104.3 75.2 97.9 68.9
tamine
96.7 112.0 88.0 7.3
110.9 139.4 101.3Na-meclo
fenamate
99.7 82.1 104.0 71.8 9.6
59.1 83.8 65.5Venom
control
104.5 93.0 79.4 7.170.6
* Values represent the percent resistance change from control produced 
by the venom in conjunction with the various blockers.
Data for the Effect of the Venom when given with Norepinephrine, 
Histamine, and PEG-,.*
Experiments (SAX Series)
SA9 SA10 SA11 SA12 Mean ± SEM




132.0 158.3 167.9 146.9 151.3 7.7NE
61.6 60.1 61.1 64.8 61.9 1.1PGE 1
His/venom 45.7 53.5 44.5 46.2 47.5 2.0
40.6 42.9 34.3 54.5 43.1 4.2NE/venom




40.4 57.5 36.0 47.9 45.4 4.7
* Values represent the percent resistance change from control produced 
by the venom in conjunction with the various vasoactive agents. 
Histamine, PGEi , and NE are shown for comparison.
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Data for Arterial and Venous Blood Histamine Content During Physalia 
venom infusion.*
Experiments (SAX Series)
Sample 1. 4. Mean ± SEM2. 3.
2436T-, A 30 30 3.51
31 1.433 30 33In V 271
25t2a 32 20 24 3.5
1.439T2V 36 39 43 39
32 3726 32 3.2t3a
41 47T3V 33 52 63 6.5
31 1.932CA 28 33 37
31 3.837 30 35CV 20
* Values represent ng/ml of serum. A = arterial samples; V = venous 
samples; and C= control samples. T-j, Tp, and correspond to 
Physalia venom doses 0.02, 0.2, and 2.0 yg/kg respectively.
APPENDIX B: Data for the in vitro experiments (SBX Series) 
In Vitro Norepinephrine Dose Response Data *
Experiments (SBX Series)
SB3 SB4 SB5 SB6 SB7 SB8
NE




0.1-3.4 0.10.4 0.00.3 -0.4 0.6
10“8 10.9 0.5 1.0 5.4 1.44.6 0.3 3.73.0
10-7 12.1 13.9 40.4 9.4 4.922.3 34.5 7.4 20.0
10-6 76.1 3.154.6 62.0 69.4 63.6 64.354.3 69.8
io-5 85.1100 84.2 96.8 92.2 2.293.2 93.4 93.0
10“4 1.8100 100 87.5 90.495.2 95.598.6 96.9
10-3 100 100 100 1 .0100 10092.9 99.3 98.9
Renal
IO"9 0.1 1.71.3 0.3 0.5 0.3-0.30.0
10-8 -1.9 -0.1 0.8 2.7 0.3 0.50.60.0 0.0
10-7 12.6 1.45.44.4 6.70.6 4.6 5.6 3.5
10-6 43.1 40.0 6.624.9 29.1 30.7 39.336.376.7
10-5 85.8 3.379.1 100 84.2 75.5 79.994.487.7
10-4 100 100 91.6 1.2100 98.5100 100 97.9
10-3 89.1100 4.369.1 81.2 88.8 99.298.8 86.6
C. Ear
IO-9 -0.10.1 0.40.6 0.5-2.4 -0.2 -0.20.8
10-8 0.2-0.8 0.9 -0.20.0 0.2-0.6 -0.4 -0.9 0.2
10-7 1.21.0 2.41.0 0.4 9.6 3.7 -0.63.40.6
10-6 13.1 15.4 28.9 13.9 24.821 .1 36.1 43.6 3.926.7
10-5 4.691.7 75.071.0 82.4 72.2 80.284.0 49.069.7
IO”4 100100 100100 100 100 0.0100 100 100
10-3 1.989.8 99.8 92.594.283.4 95.8 89.6 97.590.3
Lingual
1.2 1.62.1 2.8 -0.610- 0.7-9.6 -0.7 -0.7
10-8 -1.2 -2.1 1.9-15.5 0.3 0.7-0.4 -0.30.0 -0.6
10-7 1.9 1.01.4 0.0 2.4-0.4 0.6 0.98.2 2.0
10-6 17.521.1 21.2 13.2 10.7 16.8 39.2 3.611.9 5.8
10-5 88.1 1.884.0 94.284.8 82.2 89.4 87.285.7 97.2
10-4 1.6100 100100 100 98.3100 100 98.787.5
10“3 100 94.0 98.0 0.8100 99.4 99.596.798.6 95.9
* Values represent percent from maximum NE induced contraction tension.
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In Vitro Static Tension Versus Active Tension Data*
Experiments (SBX Series)
SB3 SB4 SB5 SB6 SB7 SB8 SB9 SB10 SB11
Tension
SB12 Mean + SEMmg
Femoral











11.10 21 .520.7 29.0 3.4
200 53.7 48.6 51.350.6 43.7 3.9
400 76.4 63.9 61.662.9 75.0 4.8
600 79.6 83.172.9 78.0 72.5 3.2
800 81 .1 81.288.9 84.5 2.0
1000 94.5 93.5 94.0 95.0 89.9 2.5
1200 100 98.5 2.694.3 93.7
1400 100 100 10098.8 96.7 2.5
1600 100 1.4100 97.0 97.3
1800 0.998.8 98.495.0 98.2
1.997.12000
Renal











17.5 5.33.4 4.20 38.5
49.1 44.6 5.2200 39.4 66.6
51.3 2.4400 53.8 53.0 54.5
68.3 56.7 69.3 3.5600 70.3





1400 93.2 0.593.3 93.2 94.4
1.21600 98.1 100 100 98.4
1800 100 99.6 99.9 96.2 3.7








7.2 33.3 34.00 50.0 55.6 50.8 9.4 42.4
70.5 81.5 20.1 51.8 
70.9 81.7 95.1 60.5 58.7 
76.0 96.6 
100 100 100 87.5 80.0
96.4 99.5 99.8 92.9 85.2 





65.4 84.8 73.4 4.2400
84.1 82.2 3.964.4 71.1 93.3600
2.491.4 100 94.8800
1.6100 99.3 96.21000
3.197.1 94.5 93.41200 96.7





8.110.5 28.0 30.576.5 5.532.9 2.1 56.2 26.1 36.5
86.2 44.6 71.3 60.1 59.6 37.5 40.0 54.5
100 74.1 81.2 32.3 77.9 87.5 67.4 67.0
97.5 100 95.5 44.5 78.8 85.9 79.5 73.4
99.2 99.3 100 56.1 92.3 98.4 81.0 86.6
96.3 76.0 92.3 100 92.6 95.7














99.3 100 98.0 0.91600
98.1 0.898.7100 96.21800
100 99.02000
* Values represent percent of maximum contraction induced by NE ED 70'
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In Vitro Venom Dose Response Data*
Experiments (SBX Series) 






SB 13 Mean ± SEMSB! 2
13.5 4.3 34.8 4.4 11.9 28.2 
19.2 11.0 42.3 13.0 6.5 32.9 
21 .5 12.8 23.7 11.5 100 47.3 
54.8 30.1 100 6.2 82.2 78.2 
100 48.3 21.3 42.8 75.1 100 
33.7100 26.7100 60.081.4
10.4 12.8 3.86.1 1 .4
21.311.725.0 30.3 4.0
0.21 61.6 24.7 37.332.7 9.5
1 .07 73.1 62.0 9.560.9 72.5
91.9 62.12.14 71.3 9.7100







94.0 37.3 47.9 44.1
53.7 83.1 
54.5 100 49.8 44.5 100
66.3 100 73.5
100 85.3 100 50.6 63.1
0.0 7.4 0.023.8
16.4 14.7 18.1 3.7
0.21 11.4 12.012.4 47.865.4 60.9 23.7
10.01.07 86.1100 62.5 70.932.6
2.14 10073.4 74.7 78.7 8.598.2 39.6




0.0 12.9 30.7 17.2 6.10.036.8 33.0 7.2
87.7 95.3 12.2 
71.3 32.2
98.7 100 60.6 
100 80.2 100 
40.1 20.7 94.4
-0.5
14.238.2 4.7 6.6 39.2 40.69.0
0.21 17.7 32.4 52.0 
61.2 58.8 73.7 
100 100 56.4
85.6 100
7.1 7.8 30.3 9.39.3
1 .07 8.9 61.7 11.061.930.8
2.14 100 82.5 7.060.0 63.7




17.7 9.7 6.4 19.4 0.0
13.1 37.6 24.2 29.8 20.8 11.2 0.0
24.4 32.3 45.1 42.4 14.9 43.4 7.7
87.5 93.8 80.3 100 56.8 41.7 32.4
96.5 96.2 100 70.9 61.4
100 100 100 93.1 82.0 100 100
19.4 10.4 3.20.0 0.5
31.4 22.424.4 4.2
0.21 18.6 34.470.8 7.2
1 .07 24.4 42.5 10.257.0
44.1 100 81.32.14 91.1 8.5
91.4100 5.54.28 56.0
* Values represent percent from maximum venom induced relaxation.
89





107.11 86.8 88.3 57.6
94.6 46.2262.0 56.02
100.9 201 .4 12.5205.33
121.3 116.3 223.1 38.14
128.272.0 69.2 27.95













114 ± 19.2 142.3 ± 25.2Mean ± SEM 115 ± 25.3 39.3 ± 7.8
* Values represent the percent relaxation from venom control 




In vitro Venom ED^q Data*
Artery Type 
Renal LingualFemoral C. EarExperiment
0.71 0.410.90SB3
0.84 0.62 0/34SB4






SB! 2 0.160.18 0.750.58
1 .46 1.115B13 0.640.49
0.67 ± 0.19 0.69 ± 0.18Mean 1 SEN 0.81 ± 0.28 0.69 ± 0.27
* Values represent Physalia Venom ED™ (yg/ml) obtained from the 
dose response curve of every experimental trial. The values which 
appear in Table were derived from the cumulative venom dose 
response curves.
